MGNX
MacroGenics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$186.87M
P/E Ratio
—
EPS
$-1.18
Beta
1.10
52W High
$3.88
52W Low
$1.19
50-Day MA
$2.83
200-Day MA
$1.94
Dividend Yield
—
Profit Margin
-49.90%
Forward P/E
60.98
PEG Ratio
0.01
About MacroGenics Inc
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville, Maryland.
Fundamentals
| Revenue (TTM) | $149.50M |
| Gross Profit (TTM) | $-33.68M |
| EBITDA | $-65.67M |
| Operating Margin | -29.30% |
| Return on Equity | -87.00% |
| Return on Assets | -17.60% |
| Revenue/Share (TTM) | $2.37 |
| Book Value | $0.88 |
| Price-to-Book | 3.44 |
| Price-to-Sales (TTM) | 1.25 |
| EV/Revenue | 0.255 |
| EV/EBITDA | -1.54 |
| Quarterly Earnings Growth (YoY) | -70.40% |
| Quarterly Revenue Growth (YoY) | 113.00% |
| Shares Outstanding | $63.56M |
| Float | $55.59M |
| % Insiders | 3.37% |
| % Institutions | 64.11% |
Historical Volatility
HV 10-Day
41.92%
HV 20-Day
52.92%
HV 30-Day
73.85%
HV 60-Day
101.60%
HV Rank
24.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($5.20 target)
1
Strong Buy1
Buy5
HoldData last updated: 4/30/2026